APM Stock Price – Aptorum Group Ltd soars 290% then collapses after venturing into infectious diseases


  • NASDAQ: APM ended Tuesday's session with a surge of 90% after hitting even higher levels.
  • Shares then collapsed back below $3, completing a pump-and-dump move. 
  • Aptorum Group launched a new unit focused on an infectious disease liquid biopsy unit.
  • Venturing into a new field involving the coronavirus implies strong growth for the low-valued company.

When a stock trades at rock-bottom levels, a small spark is all that is needed to trigger a surge. Aptorum Group Ltd nearly quadrupled in value in Tuesday's intense session, closing at $4.76 after already hitting a high of $14.23. Shares then collapsed back below $3 on a Wednesday session dominated by bears, taking the price back nearly to Monday's levels. On Thursday, trading action was quiet, with NASDAQ:APM closing at $2.89 after staying the whole session between $2.7 and $3.1.

APM stock price chart

After the recent leap and plunge, NASDAQ: APM's market capitalization is only $87.82 million. Can it rise?

APM Stock News

Aptorum jumped after announcing the launch of Aptorum Innovations, a subsidiary focused on infectious disease liquid biopsy diagnostics. When speaking of diseases that spread rapidly, SARS-Cov-2 – the virus behind COVID-19 – immediately comes to mind.

Indeed, Aptorum has in-licensed exclusive rights to develop novel molecular-based rapid pathogen identification and detection diagnostics (RPIDD) technology with a Singapore-based company called Accelerate Technologies PTE Ltd. The fir is the commercialization arm of the city-state's Agency for Science, Technology, and Research. 

The collaboration with a firm backed by Singapore – a country that successfully battled the coronavirus, is inspiring investors.

While several COVID-19 vaccines are at a late stage, there is still room for those specializing in rapid identification of this coronavirus and potentially new ones that could appear in recent years. It is essential to note that the full mitigation of the original SARS disease from 2002-2003 was never fully achieved. 

Broader markets are focused on the chaotic presidential debate – which veered away from the virus – yet its prominence is still critical for investors. 

See Presidential Debate: Stocks set to suffer on Trump's refusal to accept the results

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD climbs to fresh multi-week high above 1.0600 after US jobs data

EUR/USD climbs to fresh multi-week high above 1.0600 after US jobs data

EUR/USD gathers bullish momentum and trades at its highest level in three weeks above 1.0600. Despite the better-than-expected Nonfarm Payrolls data from the US, the US Dollar (USD) stays under bearish pressure and helps the pair stretch higher.

EUR/USD News
GBP/USD tests 1.2800 on renewed USD weakness

GBP/USD tests 1.2800 on renewed USD weakness

GBP/USD extends its weekly advance and trades near 1.2800 in the American session on Friday. The US Dollar stays on the back foot as markets assess the details of the mixed November jobs report, allowing the pair to hold its ground.

GBP/USD News
Gold stays below $2,650 after of US NFP report

Gold stays below $2,650 after of US NFP report

Gold recovers from the two-week low it set earlier in the day but remains below $2,650 in the American session on Friday. The benchmark 10-year US Treasury bond yield edges lower below 4.2% after US labor market data and supports XAU/USD.

Gold News
Week ahead: November’s US CPI rates, ECB, RBA and BoC to move the markets

Week ahead: November’s US CPI rates, ECB, RBA and BoC to move the markets

The week is about to come to an end, and we have a look at what next week has in store for the markets. We highlight the release of the US CPI rates for November and from the Eurozone ECB are to release its interest rate decisions.

Read more
ECB: A disputed 25bp rate cut

ECB: A disputed 25bp rate cut

Next week, the ECB is set to cut rates for the fourth time this year. Unlike the previous three cuts, the outcome of next week’s rate decision is not given as 1) the restrictive policy stance, 2) the deteriorating growth outlook, and 3) inflation at target has opened discussions of a 50bp cut.

Read more
Best Forex Brokers with Low Spreads

Best Forex Brokers with Low Spreads

VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.

Read More

Forex MAJORS

Cryptocurrencies

Signatures